{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T10:55:39Z","timestamp":1792839339321,"version":"4.5.0"},"reference-count":49,"publisher":"BMJ","issue":"7","funder":[{"name":"EU","award":["634579"],"award-info":[{"award-number":["634579"]}]},{"name":"EU","award":["H2020-PHC-2014-2015\/H2020-PHC-2014"],"award-info":[{"award-number":["H2020-PHC-2014-2015\/H2020-PHC-2014"]}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MC_PC_13045"],"award-info":[{"award-number":["MC_PC_13045"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013342","name":"NIHR Imperial Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013342","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Gut"],"accepted":{"date-parts":[[2024,3,17]]},"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Targeting bacterial translocation in cirrhosis is limited to antibiotics with risk of antimicrobial resistance. This study explored the therapeutic potential of a non-absorbable, gut-restricted, engineered carbon bead adsorbent, Yaq-001 in models of cirrhosis and acute-on-chronic liver failure (ACLF) and, its safety and tolerability in a clinical trial in cirrhosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>\n                      Performance of Yaq-001 was evaluated\n                      <jats:italic>in vitro<\/jats:italic>\n                      . Two-rat models of cirrhosis and ACLF, (4 weeks, bile duct ligation with or without lipopolysaccharide), receiving Yaq-001 for 2 weeks; and two-mouse models of cirrhosis (6-week and 12-week carbon tetrachloride (CCl4)) receiving Yaq-001 for 6 weeks were studied. Organ and immune function, gut permeability, transcriptomics, microbiome composition and metabolomics were analysed. The effect of faecal water on gut permeability from animal models was evaluated on intestinal organoids. A multicentre, double-blind, randomised, placebo-controlled clinical trial in 28 patients with cirrhosis, administered 4 gr\/day Yaq-001 for 3 months was performed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Yaq-001 exhibited rapid adsorption kinetics for endotoxin.\n                      <jats:italic>In vivo<\/jats:italic>\n                      , Yaq-001 reduced liver injury, progression of fibrosis, portal hypertension, renal dysfunction and mortality of ACLF animals significantly. Significant impact on severity of endotoxaemia, hyperammonaemia, liver cell death, systemic inflammation and organ transcriptomics with variable modulation of inflammation, cell death and senescence in the liver, kidneys, brain and colon was observed. Yaq-001 reduced gut permeability in the organoids and impacted positively on the microbiome composition and metabolism. Yaq-001 regulated as a device met its primary endpoint of safety and tolerability in the clinical trial.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study provides strong preclinical rationale and safety in patients with cirrhosis to allow clinical translation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT03202498\">NCT03202498<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/gutjnl-2023-330699","type":"journal-article","created":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T13:25:25Z","timestamp":1713187525000},"page":"1183-1198","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":25,"title":["Clinical, experimental and pathophysiological effects of Yaq-001: a non-absorbable, gut-restricted adsorbent in models and patients with cirrhosis"],"prefix":"10.1136","volume":"73","clinical-trial-number":[{"clinical-trial-number":"nct03202498","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct03202498","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Jinxia","family":"Liu","sequence":"first","affiliation":[{"name":"Liver Failure Group, UCL Institute for Liver & Digestive Health, Division of Medicine, London, UK"},{"name":"Department of Gastroenterology, Affiliated Hospital of Nantong University, Nantong, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"MacNaughtan","sequence":"additional","affiliation":[{"name":"Liver Failure Group, UCL Institute for Liver & Digestive Health, Division of Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annarein J C","family":"Kerbert","sequence":"additional","affiliation":[{"name":"Liver Failure Group, UCL Institute for Liver & Digestive Health, Division of Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theo","family":"Portlock","sequence":"additional","affiliation":[{"name":"Centre for Host-Microbiome Interactions, Faculty of Dentistry, Oral & Craniofacial Sciences, King\u2019s College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Mart\u00ednez Gonzalez","sequence":"additional","affiliation":[{"name":"Hospital Ram\u00f3n y Cajal, IRYCIS, CIBEREHD, Universidad de Alcal\u00e1, Madrid, Spain"},{"name":"Liver Unit, Hospital Vall d\u2019Hebron, Universitat Aut\u00f3noma, CIBERehd, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Jin","sequence":"additional","affiliation":[{"name":"Centre for Host-Microbiome Interactions, Faculty of Dentistry, Oral & Craniofacial Sciences, King\u2019s College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick","family":"Clasen","sequence":"additional","affiliation":[{"name":"Centre for Host-Microbiome Interactions, Faculty of Dentistry, Oral & Craniofacial Sciences, King\u2019s College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abeba","family":"Habtesion","sequence":"additional","affiliation":[{"name":"Liver Failure Group, UCL Institute for Liver & Digestive Health, Division of Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huoyan","family":"Ji","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Affiliated Hospital of Nantong University, Nantong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of Pathology, Affiliated Hospital of Nantong University, Nantong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Phillips","sequence":"additional","affiliation":[{"name":"Liver Failure Group, UCL Institute for Liver & Digestive Health, Division of Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"De Chiara","sequence":"additional","affiliation":[{"name":"Liver Failure Group, UCL Institute for Liver & Digestive Health, Division of Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganesh","family":"Ingavle","sequence":"additional","affiliation":[{"name":"Centre for Regenerative Medicine and Devices, School of Applied Sciences, University of Brighton, Brighton, UK"},{"name":"Symbiosis Centre for Stem Cell Research (SCSCR), Symbiosis School of Biological Sciences (SSBS), Symbiosis International (Deemed University), Pune, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesar","family":"Jimenez","sequence":"additional","affiliation":[{"name":"Liver Unit, Hospital Vall d\u2019Hebron, Universitat Aut\u00f3noma, CIBERehd, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3219-6963","authenticated-orcid":false,"given":"Giacomo","family":"Zaccherini","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy"},{"name":"Unit of Semeiotics, Liver and Alcohol-related Diseases, University of Bologna Hospital of Bologna Sant'Orsola-Malpighi Polyclinic, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Husi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Inselspital University Hospital Bern, Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel Angel","family":"Rodriguez Gandia","sequence":"additional","affiliation":[{"name":"Hospital Universitario Ramon y Cajal, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Cordero","sequence":"additional","affiliation":[{"name":"Symbiosis Centre for Stem Cell Research (SCSCR), Symbiosis School of Biological Sciences (SSBS), Symbiosis International (Deemed University), Pune, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junpei","family":"Soeda","sequence":"additional","affiliation":[{"name":"Liver Failure Group, UCL Institute for Liver & Digestive Health, Division of Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynda","family":"McConaghy","sequence":"additional","affiliation":[{"name":"Yaqrit Discovery Limited. The Elms Courtyard, Bromesberrow, Ledbury, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jude","family":"Oben","sequence":"additional","affiliation":[{"name":"Liver Failure Group, UCL Institute for Liver & Digestive Health, Division of Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Church","sequence":"additional","affiliation":[{"name":"Yaqrit Discovery Limited. The Elms Courtyard, Bromesberrow, Ledbury, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia V","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Surgery and Cancer, Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haifeng","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Affiliated Hospital of Nantong University, Nantong, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aarti","family":"Jalan","sequence":"additional","affiliation":[{"name":"King's College Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pere","family":"Gines","sequence":"additional","affiliation":[{"name":"Liver Unit, Hospital Clinic of Barcelona, IDIBAPS, Faculty of Medicine and Health sciences, University of Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsa","family":"Sol\u00e0","sequence":"additional","affiliation":[{"name":"Liver Unit, Hospital Clinic of Barcelona, IDIBAPS, Faculty of Medicine and Health sciences, University of Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Eaton","sequence":"additional","affiliation":[{"name":"Institute of Child Health, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carrie","family":"Morgan","sequence":"additional","affiliation":[{"name":"Yaqrit Discovery Limited. The Elms Courtyard, Bromesberrow, Ledbury, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Kowalski","sequence":"additional","affiliation":[{"name":"Yaqrit Discovery Limited. The Elms Courtyard, Bromesberrow, Ledbury, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Green","sequence":"additional","affiliation":[{"name":"Yaqrit Discovery Limited. The Elms Courtyard, Bromesberrow, Ledbury, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Gander","sequence":"additional","affiliation":[{"name":"Tissue Access for Patient Benefit, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8222-4555","authenticated-orcid":false,"given":"Lindsey A","family":"Edwards","sequence":"additional","affiliation":[{"name":"Centre for Host Microbiome Interactions, Faculty of Dentistry, Oral & Craniofacial Sciences, Guy's Tower, Guy's Hospital, King\u2019s College London, London, UK"},{"name":"Institute of Liver Studies, School of Immunology and Microbial Sciences, Faculty of Life Sciences and Medicine, King\u2019s College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I Jane","family":"Cox","sequence":"additional","affiliation":[{"name":"The Roger Williams Institute of Hepatology, Foundation for Liver Research, London, UK"},{"name":"Faculty of Life Sciences and Medicine, King's College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Cortez-Pinto","sequence":"additional","affiliation":[{"name":"Cl\u00ednica Universit\u00e1ria de Gastrenterologia, Laborat\u00f3rio de Nutri\u00e7\u00e3o, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Avery","sequence":"additional","affiliation":[{"name":"Yaqrit Limited, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reiner","family":"Wiest","sequence":"additional","affiliation":[{"name":"UVCM Gastroenterology, University Bern, Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francois","family":"Durand","sequence":"additional","affiliation":[{"name":"Hepatology and Liver Intensive Care, Hospital Beaujon, Clichy, University paris Cit\u00e9, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Caraceni","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy"},{"name":"Unit of Semeiotics, Liver and Alcohol Related Diseases, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Elosua","sequence":"additional","affiliation":[{"name":"C\/de Joan G\u00fcell, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Vila","sequence":"additional","affiliation":[{"name":"C\/de Joan G\u00fcell, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Pavesi","sequence":"additional","affiliation":[{"name":"European Foundation for the Study of Chronic Liver Failure (EF CLIF), Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente","family":"Arroyo","sequence":"additional","affiliation":[{"name":"European Foundation for the Study of Chronic Liver Failure (EF CLIF), Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Davies","sequence":"additional","affiliation":[{"name":"Liver Failure Group, UCL Institute for Liver & Digestive Health, Division of Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajeshwar P","family":"Mookerjee","sequence":"additional","affiliation":[{"name":"Liver Failure Group, UCL Institute for Liver & Digestive Health, Division of Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Vargas","sequence":"additional","affiliation":[{"name":"Liver Unit, Hospital Vall d\u2019Hebron, Universitat Aut\u00f3noma, CIBERehd, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Sandeman","sequence":"additional","affiliation":[{"name":"Centre for Regenerative Medicine and Devices, School of Applied Sciences, University of Brighton, Brighton, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5696-359X","authenticated-orcid":false,"given":"Gautam","family":"Mehta","sequence":"additional","affiliation":[{"name":"Liver Failure Group, UCL Institute for Liver & Digestive Health, Division of Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed","family":"Shoaie","sequence":"additional","affiliation":[{"name":"Centre for Host-Microbiome Interactions, Faculty of Dentistry, Oral & Craniofacial Sciences, King\u2019s College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Marchesi","sequence":"additional","affiliation":[{"name":"Division of Digestive Diseases, Department of Metabolism, Digestion and Reproduction, St Mary\u2019s Hospital, Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9131-2592","authenticated-orcid":false,"given":"Agust\u00edn","family":"Albillos","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Hospital Universitario Ramon y Cajal, Universidad de Alcal\u00e1, Instituto Ram\u00f3n y Cajal de Investigaci\u00f3n Sanitaria (IRYCIS), Centro de Investigaci\u00f3n Biom\u00e9dica en Red en Enfermedades Hep\u00e1ticas y Digestivas (CIBEREHD), Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fausto","family":"Andreola","sequence":"additional","affiliation":[{"name":"Liver Failure Group, UCL Institute for Liver & Digestive Health, Division of Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7747-4015","authenticated-orcid":false,"given":"Rajiv","family":"Jalan","sequence":"additional","affiliation":[{"name":"Liver Failure Group, UCL Institute for Liver & Digestive Health, Division of Medicine, London, UK"},{"name":"European Foundation for the Study of Chronic Liver Failure (EF CLIF), Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,4,15]]},"reference":[{"key":"2025120518511871000_73.7.1183.1","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-57284-z","article-title":"Recombinant alkaline phosphatase prevents acute on chronic liver failure","volume":"10","author":"Engelmann","year":"2020","journal-title":"Sci Rep"},{"key":"2025120518511871000_73.7.1183.2","doi-asserted-by":"crossref","first-page":"144","DOI":"10.5604\/01.3001.0012.7906","article-title":"Metabolomics discloses a new non-invasive method for the diagnosis and prognosis of patients with alcoholic hepatitis","volume":"18","author":"Michelena","year":"2019","journal-title":"Ann Hepatol"},{"key":"2025120518511871000_73.7.1183.3","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jhep.2020.01.011","article-title":"Toll-like receptor 4 is a therapeutic target for prevention and treatment of liver failure","volume":"73","author":"Engelmann","year":"2020","journal-title":"J Hepatol"},{"key":"2025120518511871000_73.7.1183.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.11.009"},{"key":"2025120518511871000_73.7.1183.5","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41575-021-00520-7","article-title":"Cirrhosis-associated immune dysfunction","volume":"19","author":"Albillos","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2025120518511871000_73.7.1183.6","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9051467","article-title":"Increased endotoxin activity is associated with the risk of developing acute-on-chronic liver failure","volume":"9","author":"Takaya","year":"2020","journal-title":"J Clin Med"},{"key":"2025120518511871000_73.7.1183.7","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.98019","article-title":"Gut microbial RNA and DNA analysis predicts hospitalizations in cirrhosis","volume":"3","author":"Bajaj","year":"2018","journal-title":"JCI Insight"},{"key":"2025120518511871000_73.7.1183.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.10.027"},{"key":"2025120518511871000_73.7.1183.9","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.12.005"},{"key":"2025120518511871000_73.7.1183.10","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/liv.12047","article-title":"Increased renal expression and urinary excretion of TLR4 in acute kidney injury associated with cirrhosis","volume":"33","author":"Shah","year":"2013","journal-title":"Liver Int"},{"key":"2025120518511871000_73.7.1183.11","doi-asserted-by":"crossref","DOI":"10.1016\/S0168-8278(15)30110-0","article-title":"O091: oral therapy with non-Absorbable carbons of controlled porosity (YAQ-001) selectively modulates stool Microbiome and its function and this is associated with restoration of immune function and Infammasome activation","volume":"62","author":"Macnaughtan","year":"2015","journal-title":"J Hepatol"},{"key":"2025120518511871000_73.7.1183.12","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2015-309861.983","article-title":"PTH-095 oral carbon therapy is associated with a selective modulation of the Microbiome in Cirrhotic rats which is associated with a significant reduction in inflammatory activation","volume":"64","author":"Macnaughtan","year":"2015","journal-title":"Gut"},{"key":"2025120518511871000_73.7.1183.13","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2021-BASL.9"},{"key":"2025120518511871000_73.7.1183.14","article-title":"190 Ast-120 (spherical carbon Adsorbent) in covert hepatic encephalopathy: results of the astute trial","volume":"58","author":"Bajaj","year":"2013","journal-title":"J Hepatol"},{"key":"2025120518511871000_73.7.1183.15","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2022.101365","article-title":"A permeability assay for Mouse intestinal Organoids","volume":"3","author":"den Daas","year":"2022","journal-title":"STAR Protoc"},{"key":"2025120518511871000_73.7.1183.16","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhepr.2020.100151","article-title":"Faecal cytokine profiling as a marker of intestinal inflammation in acutely decompensated cirrhosis","volume":"2","author":"Riva","year":"2020","journal-title":"JHEP Rep"},{"key":"2025120518511871000_73.7.1183.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.01.024"},{"key":"2025120518511871000_73.7.1183.18","doi-asserted-by":"publisher","DOI":"10.1016\/S1590-8658(01)80134-1"},{"key":"2025120518511871000_73.7.1183.19","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.jhep.2020.07.046","article-title":"Clinical features and evolution of bacterial infection-related acute-on-chronic liver failure","volume":"74","author":"Wong","year":"2021","journal-title":"J Hepatol"},{"key":"2025120518511871000_73.7.1183.20","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.jhep.2022.07.006","article-title":"Combination of G-CSF and a Tlr4 inhibitor reduce inflammation and promote regeneration in a mouse model of ACLF","volume":"77","author":"Engelmann","year":"2022","journal-title":"J Hepatol"},{"key":"2025120518511871000_73.7.1183.21","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.jceh.2021.08.010","article-title":"Rifaximin vs. norfloxacin for spontaneous bacterial Peritonitis prophylaxis: a randomized controlled trial","volume":"12","author":"Praharaj","year":"2022","journal-title":"J Clin Exp Hepatol"},{"key":"2025120518511871000_73.7.1183.22","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jhep.2021.09.010","article-title":"Rifaximin-alpha reduces gut-derived inflammation and Mucin degradation in cirrhosis and encephalopathy: RIFSYS randomised controlled trial","volume":"76","author":"Patel","year":"2022","journal-title":"J Hepatol"},{"key":"2025120518511871000_73.7.1183.23","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/151.6.1012"},{"key":"2025120518511871000_73.7.1183.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2004.10.019"},{"key":"2025120518511871000_73.7.1183.25","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.872428","article-title":"The apparent Asymmetrical relationship between small bowel bacterial overgrowth, Endotoxemia, and liver steatosis and fibrosis in Cirrhotic and non-Cirrhotic patients: a single-center pilot study","volume":"9","author":"Scarpellini","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"2025120518511871000_73.7.1183.26","doi-asserted-by":"publisher","DOI":"10.4240\/wjgs.v2.i3.61"},{"key":"2025120518511871000_73.7.1183.27","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41577-022-00746-9","article-title":"IL-17 and IL-17-producing cells in protection versus pathology","volume":"23","author":"Mills","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"2025120518511871000_73.7.1183.28","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.03688-21","article-title":"Interleukin-17 weakens the NAFLD\/NASH process by facilitating intestinal barrier restoration depending on the gut Microbiota","volume":"13","author":"He","year":"2022","journal-title":"mBio"},{"key":"2025120518511871000_73.7.1183.29","doi-asserted-by":"crossref","first-page":"4633","DOI":"10.1038\/s41596-021-00589-z","article-title":"Intestinal organoid cocultures with microbes","volume":"16","author":"Puschhof","year":"2021","journal-title":"Nat Protoc"},{"key":"2025120518511871000_73.7.1183.30","doi-asserted-by":"publisher","DOI":"10.1136\/gut.52.8.1182"},{"key":"2025120518511871000_73.7.1183.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.03.014"},{"key":"2025120518511871000_73.7.1183.32","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.jcmgh.2018.09.018","article-title":"Host genetic variant in CXCL16 may be associated with hepatitis B virus-related acute liver failure","volume":"7","author":"Ajmera","year":"2019","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"2025120518511871000_73.7.1183.33","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-021-04442-9","article-title":"The role of RIPK1 mediated cell death in acute on chronic liver failure","volume":"13","author":"Kondo","year":"2021","journal-title":"Cell Death Dis"},{"key":"2025120518511871000_73.7.1183.34","doi-asserted-by":"crossref","first-page":"5002","DOI":"10.3390\/ijms20205002","article-title":"TGF-beta signaling in cellular senescence and aging-related pathology","volume":"20","author":"Tominaga","year":"2019","journal-title":"IJMS"},{"key":"2025120518511871000_73.7.1183.35","doi-asserted-by":"crossref","DOI":"10.3390\/cells8111419","article-title":"TGF-beta in hepatic Stellate cell activation and liver Fibrogenesis-updated 2019","volume":"8","author":"Dewidar","year":"2019","journal-title":"Cells"},{"key":"2025120518511871000_73.7.1183.36","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-020-00630-3"},{"key":"2025120518511871000_73.7.1183.37","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.668459","article-title":"The Lipopolysaccharide-sensing Caspase(S)-4\/11 are activated in cirrhosis and are causally associated with progression to multi-organ injury","volume":"9","author":"Soffientini","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"2025120518511871000_73.7.1183.38","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201810248","article-title":"Inflammasomes in neuroinflammatory and neurodegenerative diseases","volume":"11","author":"Voet","year":"2019","journal-title":"EMBO Mol Med"},{"key":"2025120518511871000_73.7.1183.39","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.cell.2019.01.044","article-title":"CCR5 is a therapeutic target for recovery after stroke and traumatic brain injury","volume":"176","author":"Joy","year":"2019","journal-title":"Cell"},{"key":"2025120518511871000_73.7.1183.40","article-title":"Ccl24 protects renal function by controlling inflammation in Podocytes","volume":"2021","author":"Wang","year":"2021","journal-title":"Dis Markers"},{"key":"2025120518511871000_73.7.1183.41","doi-asserted-by":"crossref","first-page":"104662","DOI":"10.1016\/j.yexmp.2021.104662","article-title":"Sarcopenia, oxidative stress and inflammatory process in muscle of cirrhotic rats - action of melatonin and physical exercise","volume":"121","author":"Rosa","year":"2021","journal-title":"Exp Mol Pathol"},{"key":"2025120518511871000_73.7.1183.42","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.jhep.2023.01.031","article-title":"Current treatment strategies and future possibilities for sarcopenia in cirrhosis","volume":"78","author":"Ebadi","year":"2023","journal-title":"J Hepatol"},{"key":"2025120518511871000_73.7.1183.43","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhepr.2022.100619","article-title":"Sarcopenia-related gut microbial changes are associated with the risk of complications in people with cirrhosis","volume":"5","author":"Lee","year":"2023","journal-title":"JHEP Rep"},{"key":"2025120518511871000_73.7.1183.44","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/s41575-020-00376-3","article-title":"Utilizing the gut microbiome in decompensated cirrhosis and acute-on-chronic liver failure","volume":"18","author":"Trebicka","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2025120518511871000_73.7.1183.45","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2016-312729"},{"key":"2025120518511871000_73.7.1183.46","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.10.003"},{"key":"2025120518511871000_73.7.1183.47","doi-asserted-by":"crossref","DOI":"10.1038\/srep26800","article-title":"Impaired gut-liver-brain axis in patients with cirrhosis","volume":"6","author":"Ahluwalia","year":"2016","journal-title":"Sci Rep"},{"key":"2025120518511871000_73.7.1183.48","first-page":"3605","article-title":"Association of disease condition with changes in intestinal Flora, and plasma Endotoxin and vascular endothelial growth factor levels in patients with liver cancer","volume":"24","author":"Jiang","year":"2020","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2025120518511871000_73.7.1183.49","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/liv.15466","article-title":"Association of gut Microbiome and primary liver cancer: a two-sample Mendelian randomization and case-control study","volume":"43","author":"Ma","year":"2023","journal-title":"Liver Int"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gutjnl-2023-330699","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T02:51:34Z","timestamp":1764989494000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gutjnl-2023-330699"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,15]]},"references-count":49,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,6,6]]},"published-print":{"date-parts":[[2024,7]]}},"alternative-id":["10.1136\/gutjnl-2023-330699"],"URL":"https:\/\/doi.org\/10.1136\/gutjnl-2023-330699","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,15]]}}}